中文 | English
Return
Total: 2133 , 1/214
Show Home Prev Next End page: GO
Author:( Feng QIANG)

1.Netrin-1:the new tumor markers in renal clear cell carcinoma

Baisheng GONG ; Qiang FENG

Asian Pacific Journal of Tropical Biomedicine 2015;(6):488-492

2.Development of Multi-function Blooding Device for Blood Sucking Insects

Yanfeng FENG ; Qiang WANG

Chinese Medical Equipment Journal 2003;0(10):-

3. Inhibitory effect of valproate on proliferation of human kidney carcinoma ACHN cells and its mechanism

Feng-Qiang YANG

Tumor 2013;33(3):229-233

4.Changes of Neurohormonal Level in Children with Congenital Heart Diseases at Pre-and Post-Interventional Therapy

yong-qiang, FENG ; wei-feng, WU

Journal of Applied Clinical Pediatrics 1986;0(01):-

5.Synthesis of 6-18F-Py-AMD3465 and the microPET/CT imaging of this agent in mice bearing A549 tumor

Nan LIU ; Qiang YOU ; Yue FENG ; Qiang WAN ; Yue CHEN

Chinese Journal of Nuclear Medicine and Molecular Imaging 2016;36(2):122-126

6.The MSCT findings of greater omentum blunt trauma

Feng WEN ; Zhenguo ZHAO ; Qiang GU

Journal of Practical Radiology 2014;(10):1661-1664

7.Correlation between obesity, type Ⅱ diabetes and colorectal neoplastic lesions

Juan FENG ; Zang ZUO ; Qiang GUO

Chinese Journal of Digestive Endoscopy 2010;27(7):356-359

8.Determination of 5-O-Methylvisamminol in Shufeng Oral Liquid by HPLC

Qiang XU ; Shudan ZHANG ; Ying FENG

Traditional Chinese Drug Research & Clinical Pharmacology 2000;0(05):-

9.A comparative study on transplantation of xenogeneic (porcine) acellular dermal matrix combined with micro-autograft or split-thickness autograft of skin

Jiake CHAI ; Qiang LIU ; Rui FENG

Medical Journal of Chinese People's Liberation Army 2001;0(08):-

10.The implementing experience of patient access schemes in UK and its implication for China

Feng CHANG ; Penglei CUI ; Qiang XIA

Chinese Journal of Health Policy 2016;9(7):60-65

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2133 , 1/214 Show Home Prev Next End page: GO